192 filings
Page 7 of 10
4
IKT
Inhibikase Therapeutics Inc
29 Jun 21
Inhibikase Therapeutics / PAUL C GRINT ownership change
7:11pm
4
Freeman Roy Lester
29 Jun 21
Inhibikase Therapeutics / Roy Lester Freeman ownership change
7:10pm
4
Dennis N Berman
29 Jun 21
Inhibikase Therapeutics / DENNIS N BERMAN ownership change
7:09pm
8-K
IKT
Inhibikase Therapeutics Inc
29 Jun 21
Submission of Matters to a Vote of Security Holders
12:00am
SC 13D
IKT
Inhibikase Therapeutics Inc
21 Jun 21
Inhibikase Therapeutics / FiveT Investment Management ownership change
12:01pm
8-K
IKT
Inhibikase Therapeutics Inc
21 Jun 21
Inhibikase Therapeutics Announces Closing of Follow-On Offering of Common Stock
9:23am
424B4
IKT
Inhibikase Therapeutics Inc
17 Jun 21
Prospectus supplement with pricing info
4:31pm
8-K
IKT
Inhibikase Therapeutics Inc
16 Jun 21
Inhibikase Therapeutics Prices Follow-On Public Offering of Common Stock
9:20am
EFFECT
IKT
Inhibikase Therapeutics Inc
16 Jun 21
Notice of effectiveness
12:15am
S-1
IKT
Inhibikase Therapeutics Inc
IPO registration
11 Jun 21
4:24pm
CORRESP
IKT
Inhibikase Therapeutics Inc
11 Jun 21
Correspondence with SEC
12:00am
CORRESP
IKT
Inhibikase Therapeutics Inc
11 Jun 21
Correspondence with SEC
12:00am
UPLOAD
IKT
Inhibikase Therapeutics Inc
3 Jun 21
Letter from SEC
12:00am
DRS
IKT
Inhibikase Therapeutics Inc
2 Jun 21
Draft registration statement
12:00am
8-K
IKT
Inhibikase Therapeutics Inc
1 Jun 21
Regulation FD Disclosure
7:30am
4
IKT
Inhibikase Therapeutics Inc
18 May 21
Inhibikase Therapeutics / Milton H. Werner ownership change
5:46pm
10-Q
2021 Q1
IKT
Inhibikase Therapeutics Inc
17 May 21
Quarterly report
4:41pm
DEFA14A
IKT
Inhibikase Therapeutics Inc
30 Apr 21
Additional proxy soliciting materials
5:21pm
DEF 14A
IKT
Inhibikase Therapeutics Inc
30 Apr 21
Definitive proxy
5:20pm
8-K
IKT
Inhibikase Therapeutics Inc
1 Apr 21
Inhibikase Therapeutics Reports Fourth Quarter and Full Year 2020 Financial Results and Highlights Recent Period Activity
1:13pm